Top 27 Roche Glycart investors
The most complete profiles first. Showing 27 of 27.
Antoine BoulangerVerified
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Anastasia KarpovaVerified
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Boyd RuttenVerified
Venture Capital, Private Equity Firm · Netherlands
Health CareWearablesHospitalsWellnessPortfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more
Verified email available
Henry ZubaidaVerified
Venture Capital, Private Equity Firm · United Kingdom
Health CareWearablesHospitalsWellnessPortfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more
Verified email available
John MontanaVerified
Venture Capital, Private Equity Firm, Investment Partner · United Kingdom
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Geert
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Holger Reithinger
Venture Capital, Investor · Germany
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more
Contact details available
Juliette Audet
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Martien van Osch
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more
Contact details available
Rogier Rooswinkel
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Wouter Joustra
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Asiya Giniatullina
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Bonnie van Wilgenburg
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Carlo Incerti
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Dan Secor
Venture Capital, Private Equity Firm · United States
Health CareWearablesHospitalsWellnessPortfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more
Contact details available
Edward Hanlon
Venture Capital, Private Equity Firm · United States
Health CareWearablesHospitalsWellnessPortfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more
Contact details available
Edwin de Graaf
Venture Capital, Private Equity Firm · Netherlands
Health CareWearablesHospitalsWellnessPortfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more
Contact details available
Jasper van Gorp
Venture Capital, Private Equity Firm · Netherlands
Health CareWearablesHospitalsWellnessPortfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more
Contact details available
Joep Heldens
Venture Capital, Private Equity Firm · Netherlands
Health CareWearablesHospitalsWellnessPortfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more
Contact details available
Kiran Dallenbach
Venture Capital, Private Equity Firm · Switzerland
Health CareChemicalLife ScienceBiotechnologyPortfolio: Noema Pharma, CareX SA, idiag, Activaero and 41 more
Contact details available
Redmar Koene
Venture Capital, Private Equity Firm · Netherlands
Health CareWearablesHospitalsWellnessPortfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more
Contact details available
Sander van Deventer
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Sanne de Jongh
Venture Capital, Private Equity Firm · Netherlands
Health CareWearablesHospitalsWellnessPortfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more
Contact details available
Stefan Fäs
Venture Capital, Private Equity Firm · Switzerland
Health CareChemicalLife ScienceBiotechnologyPortfolio: Noema Pharma, CareX SA, idiag, Activaero and 41 more
Contact details available
Stefan Luzi, PhD
Venture Capital, Private Equity Firm · Netherlands
Health CareWearablesHospitalsWellnessPortfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more
Contact details available
Tom Klein Robbenhaar
Venture Capital, Private Equity Firm · Netherlands
Health CareWearablesHospitalsWellnessPortfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more
Contact details available
Vincent van Houten
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Frequently asked questions
How many Roche Glycart investors are on Angel Roster?
Angel Roster lists 27 Roche Glycart investors. 5 of them (19%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (27), Private Equity Firms (19) and Investment Partner Investors (6). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Roche Glycart investors invest in?
Among those that list a stage, the most common are Seed (7).
Where are Roche Glycart investors based?
Most are based in the Netherlands (20), the United States (2) and Switzerland (2).
Which companies have Roche Glycart investors backed?
The most-backed portfolio companies among them are Amphista Therapeutics (25), Santaris Pharma (25), Pieris AG (25), SANIFIT (25) and AM Pharma (25).
How do I contact Roche Glycart investors?
Create a free Angel Roster account to search and filter all 27, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.